Response and outcomes of maintenance avelumab after platinum-based chemotherapy (PBC) in patients (pts) with advanced urothelial carcinoma (aUC): "Real world" experience.

被引：0

作者：

Bakaloudi, Dimitra Rafailia

Talukder, Rafee

Makrakis, Dimitrios

Agarwal, Neeraj

Tripathi, Nishita

Bamias, Aristotelis

Zakopoulou, Roubini

Brown, Jason

Korolewicz, James

Fulgenzi, Claudia A. M.

Jindal, Tanya

Murgic, Jure

Frobe, Ana

Johnson, Jeffrey

Drakaki, Alexandra

Rodriguez-Vida, Alejo

Rey-Cardenas, Macarena

Buznego, Lucia Andrea Alonso

Khaki, Ali Raza

Grivas, Petros

机构：

[1] Univ Washington, Seattle, WA USA

[2] Albert Einstein Coll Med, Dept Med, Jacobi Med Ctr, Bronx, NY USA

[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[4] Univ Athens, Athina, Greece

[5] Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Dept Clin Therapeut, Sch Med, Athens, Greece

[6] Univ Hosp Seidman Canc Ctr, Div Oncol, Cleveland, OH USA

[7] Imperial Coll, London, England

[8] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, London, England

[9] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[10] KBC Sestre Milosrdnice, Zagreb, ON, Croatia

[11] Mercy Univ, Zagreb Med Sch, Dept Oncol, Univ Hosp Ctr Sisters, Zagreb, Croatia

[12] Univ Iowa, Div Oncol, Dept Med, Iowa City, IA USA

[13] UCLA, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA USA

[14] Hosp Mar, IMIM Res Inst, Barcelona, Spain

[15] Hosp Univ 12 Octubre, Madrid, Spain

[16] Marque de Valdecilla Univ Hosp, Santander, Spain

[17] Stanford Univ, Stanford, CA USA

[18] Fred Hutchinson Canc Ctr, Seattle, WA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

472

引用

页数：1

共 50 条

[41] PEMBROLIZUMAB VS. CONVENTIONAL CHEMOTHERAPY AFTER FIRST-LINE PLATINUM-BASED CHEMOTHERAPY FOR ADVANCED UROTHELIAL CARCINOMA IN REAL-WORLD PRACTICE: A MULTICENTER RETROSPECTIVE STUDY
Narita, Takuma
Hatakeyama, Shingo
Numakura, Kazuyuki
Kobayashi, Mizuki
Muto, Yumina
Saito, Mitsuru
Narita, Shintaro
Tanaka, Toshikazu
Noro, Daisuke
Tokui, Noriko
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Habuchi, Tomonori
Ohyama, Chikara
JOURNAL OF UROLOGY, 2021, 206 : E767 - E767
[42] Safety of Vinflunine in Patients with Advanced Urothelial Carcinoma Refractory to Platinum-based Chemotherapy: A Prospective Pilot Study
Abdel-Malek, Raafat
Shohdy, Kyrillus S.
Abbas, Noha
Ismail, Mohamed
Hamada, Emad
Abdel-Kader, Yasser
CURRENT DRUG SAFETY, 2019, 14 (01) : 31 - 36
[43] A Review Of Real-World Treatment Outcomes Of mNSCLC Patients Following Progression On Or After Platinum-Based Chemotherapy
Koh, C.
Furnback, W.
Chavez, G.
Higgins, C.
Kim, J.
Proescholdt, C.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S344 - S344
[44] Outcomes by complete response to first-line pembrolizumab or platinum-based chemotherapy in advanced urothelial carcinoma (UC) in KEYNOTE-361
Ozyilkan, Ozgur
McDermott, Raymond S.
Juan-Fita, Maria Jose
Semenov, Andrey
Alekseev, Boris
Berger, Raanan
Bae, Woo Kyun
Danchaivijitr, Pongwut
Lin, Jianxin
Bavle, Abhishek Amar
Imai, Kentaro
Arslan, Cagatay
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[45] First-line Maintenance Therapy in adult Patients with locally advanced or metastatic Urothelial Carcinoma who are progression-free after platinum-based Chemotherapy
Rexer, Heidrun
Gschwend, Jurgen
Merseburger, Axel S.
AKTUELLE UROLOGIE, 2024, 55 (04) : 297 - 298
[46] Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in older patients (pts)
Gupta, S.
Climent Duran, M. A.
Sridhar, S.
Powles, T. B.
Bellmunt, J.
Tyroller, K.
Guenther, S.
di Pietro, A.
Grivas, P.
ANNALS OF ONCOLOGY, 2023, 34 : S1207 - S1207
[47] Efficacy of talazoparib and avelumab as a maintenance treatment in patients with advanced/metastatic urothelial carcinoma (mUC) whose disease did not progress after a first-line platinum-based chemotherapy (PBCT): The GETUG-TALASUR trial
Coquan, E.
Boughalem, E.
Pouessel, D.
Lequesne, J.
Calcagno, F.
Grellard, J-M.
Christy, F.
Mahammedi, H.
Ladoire, S.
Borchiellini, D.
Leman, R.
Bazille, C.
Fontugne, J.
Crouzet, L.
Flechon, A.
Serrate, C.
Gravis, G.
Clarisse, B.
Vuillemin, A. Thiery
Lobbedez, F. Joly
ANNALS OF ONCOLOGY, 2024, 35 : S1144 - S1145
[48] TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.
Mollica, Veronica
Tassinari, Elisa
Santoni, Matteo
Marchese, Paola Valeria
Giunchi, Francesca
Maloberti, Thais
Tateo, Valentina
Ricci, Costantino
Rosellini, Matteo
Marchetti, Andrea
Fiorentino, Michelangelo
De Biase, Dario
Massari, Francesco
PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
[49] The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma
Okita, Kazutaka
Hatakeyama, Shingo
Hagiwara, Kazuhisa
Suzuki, Yuichiro
Tanaka, Toshikazu
Noro, Daisuke
Tokui, Noriko
Fujita, Naoki
Konishi, Sakae
Okamoto, Teppei
Yoneyama, Tohru
Yamamoto, Hayato
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Ohyama, Chikara
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (12) : 832.e17 - 832.e23
[50] Avelumab first-line maintenance (1LM) for advanced urothelial carcinoma (aUC): Long-term outcomes from JAVELIN Bladder 100 in patients (pts) with low tumor burden
Bellmunt, Joaquim
Powles, Thomas
Park, Se Hoon
Voog, Eric
Valderrama, Begona Perez
Gurney, Howard
Ullen, Anders
Loriot, Yohann
Sridhar, Srikala S.
Tsuchiya, Norihiko
Sternberg, Cora N.
Aragon-Ching, Jeanny B.
Petrylak, Daniel P.
Duran, Miguel A. Climent
Tyroller, Karin
Hoffman, Jason
Jacob, Natalia
Grivas, Petros
Gupta, Shilpa
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →